Table 1. Clinical pathological data for gastric cancer patients with different numbers of harvested lymph nodes.
Clinical pathological data | Fewer than 15 harvested lymph nodes (n = 346 cases) | Harvested lymph nodes (15–29) (n = 601 cases) | Greater than 30 harvested lymph nodes (n = 154 cases) | |||||||
Cases | % | Cases | % | Cases | % | P value | ||||
Age (Years) | Median | 61 | 57 | 58 | 0.316 | |||||
Range | 28–83 | 18–82 | 22–76 | |||||||
Sex | Male | 245 | 70.8 | 401 | 66.7 | 106 | 68.8 | |||
Female | 101 | 29.2 | 200 | 33.3 | 48 | 31.2 | 0.424 | |||
Tumour location | Gastric cardia | 211 | 61.0 | 232 | 38.6 | 42 | 27.3 | |||
Middle | 29 | 8.4 | 115 | 19.1 | 31 | 20.1 | ||||
Antrum | 84 | 24.3 | 234 | 38.9 | 75 | 48.7 | ||||
Total stomach | 2 | 0.6 | 7 | 1.2 | 4 | 2.6 | ||||
Remnant stomach* | 20 | 5.8 | 13 | 2.2 | 2 | 1.3 | <0.001 | |||
Surgery | Proximal gastrectomy | 218 | 63.0 | 219 | 36.4 | 42 | 27.3 | |||
Distal gastrectomy | 93 | 26.9 | 293 | 48.8 | 85 | 55.2 | ||||
Total gastrectomy | 35 | 10.1 | 89 | 14.8 | 27 | 17.5 | <0.001 | |||
Tumour size | <3 cm | 52 | 15.0 | 101 | 16.8 | 14 | 9.1 | |||
≥3 cm | 294 | 85.0 | 500 | 83.2 | 140 | 90.9 | 0.059 | |||
Borrmann type | I | 12 | 3.8 | 18 | 3.4 | 2 | 1.3 | |||
II | 184 | 57.5 | 286 | 53.4 | 60 | 39.5 | ||||
III | 107 | 33.4 | 210 | 39.2 | 77 | 50.7 | ||||
IV | 17 | 5.3 | 22 | 4.1 | 13 | 8.6 | 0.002 | |||
Histological grade | High-differentiation | 4 | 1.2 | 6 | 1.0 | 0 | 0 | |||
Median-differentiation | 111 | 32.1 | 147 | 24.5 | 23 | 14.9 | ||||
Low-differentiation | 164 | 47.4 | 330 | 54.9 | 102 | 66.2 | ||||
Poor-differentiation** | 67 | 19.4 | 118 | 19.6 | 29 | 18.8 | 0.001 | |||
T staging*** | T1 | 26 | 7.5 | 65 | 10.8 | 2 | 1.3 | |||
T2 | 16 | 4.6 | 45 | 7.5 | 4 | 2.6 | ||||
T3 | 9 | 2.6 | 32 | 5.3 | 0 | 0.0 | ||||
T4a | 233 | 67.3 | 348 | 57.9 | 133 | 86.4 | ||||
T4b | 62 | 17.9 | 111 | 18.5 | 15 | 9.7 | <0.001 | |||
N staging*** | N0 | 133 | 38.4 | 185 | 30.8 | 33 | 21.4 | |||
N1 | 79 | 22.8 | 119 | 19.8 | 21 | 13.6 | ||||
N2 | 94 | 27.2 | 87 | 14.5 | 43 | 27.9 | ||||
N3a | 40 | 11.6 | 156 | 26.0 | 37 | 24.0 | ||||
N3b | 0 | 0.0 | 54 | 9.0 | 20 | 13.0 | <0.001 | |||
Adjuvant Chemotherapy | Yes | 254 | 73.4 | 442 | 73.5 | 121 | 78.6 | |||
No | 92 | 26.6 | 159 | 26.5 | 33 | 21.4 | 0.410 |
These 35 remnant stomach patients all had a more than 5 years history of the gastrectomy because of the gastric ulcer.
Poorly-differentiated cells: signet ring cell carcinoma, mucinous adenocarcinoma, undifferentiated carcinoma, etc.
The T and N stagings for this group of patients are defined according to the AJCC’s 7th TNM staging system for gastric cancer.